マロニル-CoAは,リポゲネシスとラン活性化を促進することによって,前立腺がんの進行とカストレーション抵抗を促進します
Yiheng Dai1, Lilong Liu2, Yongbo Luo1
1First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Cancer research
|August 27, 2025
まとめ
前立腺がん (PCa) のマロニル-CoAの増加は,脂質生成を促進し,タンパク質を改変することによって,腫瘍の成長と薬剤耐性を促進する. マロニル-CoA経路を標的とした治療は,PCaに対する潜在的な治療戦略です.
科学分野:
- 生物化学
- 腫瘍学
- 代謝経路
背景:
- マロニル-CoAは,脂質生成と脂肪酸の酸化を調節する重要な代謝物です.
- がん細胞は変化した代謝状態を示し,腫瘍の発達と薬剤耐性におけるマロニル-CoAの役割を示唆する.
- 前立腺がん (PCa),特にカストレーション抵抗性PCa (CRPC) は,異常な脂質代謝によって特徴付けられています.
研究 の 目的:
- 前立腺がんの進行と薬剤耐性におけるマロニル-CoA蓄積の役割を調査する.
- PCaにおけるマロニル-CoA経路を標的とした治療の可能性を調査する.
主な方法:
- PCa組織におけるマロニル-コア濃度の定量化
- マロニル-コアがリポゲネシス,エンドプラズマ網膜ホメオスタシス,ミトコンドリア機能に及ぼす影響の分析.
- マロニル-CoAデカルボキシラーゼ (MLYCD) 発現とその展開タンパク質応答への影響の調査.
- リンジンのマロニル化,特にRan K141の評価と,アンドロゲン受容体の活性に対する影響.
主要な成果:
- マロニル-コア濃度はPCa,特にCRPCで上昇しています.
- 蓄積されたマロニル-CoAはリポゲネシス,ERホメオスタシス,ミトコンドリア機能を促進し,PCaの進行を促します.
- MLYCDの復元は,マロニル-CoAを消費することによって,展開されたタンパク質応答を活性化します.
- マロニル-CoAはRan K141のリジンマロニル化を促進し,その活性とアンドロゲン受容体のシグナル伝達を強化し,PCaの発達と抗アンドロゲン抵抗に寄与する.
結論:
- マロニル- CoAは,代謝の調節とタンパク質のマロニル化によってPCAの進行に重要な役割を果たします.
- マロニル-CoA軸は前立腺がんの潜在的バイオマーカーであり,治療対象である.
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K


